共 273 条
Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies
被引:6
作者:
Elkrief, Laure
[1
,2
]
Hernandez-Gea, Virginia
[3
,4
,5
]
Senzolo, Marco
[6
]
Albillos, Agustin
[4
,7
]
Baiges, Anna
[3
,4
,5
]
Berzigotti, Annalisa
[8
]
Bureau, Christophe
[9
]
Murad, Sarwa Darwish
[10
]
De Gottardi, Andrea
[11
]
Durand, Francois
[2
,12
]
Garcia-Pagan, Juan-Carlos
[3
,4
,5
]
Lisman, Ton
[15
]
Mandorfer, Mattias
[16
]
Mclin, Valerie
[17
]
Moga, Lucile
[2
,12
]
Nery, Filipe
[18
]
Northup, Patrick
[19
,20
]
Nuzzo, Alexandre
[21
,22
]
Paradis, Valerie
[13
]
Patch, David
[23
]
Payance, Audrey
[2
,12
]
Plaforet, Vincent
[14
]
Plessier, Aurelie
[2
,12
]
Poisson, Johanne
[2
,24
]
Roberts, Lara
[25
]
Salem, Riad
[26
]
Sarin, Shiv
[27
]
Shukla, Akash
[28
]
Toso, Christian
[29
]
Tripathi, Dhiraj
[30
,31
]
Valla, Dominique
[2
,12
]
Ronot, Maxime
[2
,14
]
Rautou, Pierre-Emmanuel
[2
,12
]
机构:
[1] Ctr Hosp Reg Univ Tours, Fac Med Tours, Serv Hepatogastroenterol, Tours, France
[2] Univ Paris Cite, Ctr Rech Inflammat, Paris, France
[3] Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer, Liver Unit, Barcelona Hepat Hemodynam Lab, Barcelona, Spain
[4] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
[5] Univ Barcelona, Dept Med & Ciencies Salut, Barcelona, Spain
[6] Univ Padua, Dept Surg Oncol & Gastroenterol, Padua, Italy
[7] Hosp Univ Ramon & Cajal, Dept Gastroenterol & Hepatol, Inst Ramon & Cajal Invest Sanit, Madrid, Spain
[8] Bern Univ Hosp, Inselspital, Dept Visceral Surg & Med, Bern, Switzerland
[9] Univ Paul Sabatier, Serv Hepatol, Hop Rangueil, Toulouse, France
[10] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[11] Univ Svizzera Italiana, Gastroenterol & Hepatol Dept, Ente Osped Cantonale, Fac Biomed Sci, Lugano, Switzerland
[12] Hop Beaujon, Serv Hepatol, AP HP, F-92110 Clichy, France
[13] Hop Beaujon, Dept Pathol, AP HP, Clichy, France
[14] Hop Beaujon, Serv Radiol, AP HP, Clichy, France
[15] Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands
[16] Med Univ Vienna, Dept Med 3, Div Gastroenterol & Hepatol, Vienna Hepat Hemodynam Lab, Vienna, Austria
[17] Univ Geneva, Swiss Pediat Liver Ctr, Dept Pediat, Gynecol & Obstet, Geneva, Switzerland
[18] Univ Porto, Sch Med & Biomed Sci, Immuno Physiol & Pharmacol Dept, Porto, Portugal
[19] NYU Langone, Transplant Inst, New York, NY USA
[20] NYU Langone, Div Gastroenterol, New York, NY USA
[21] Hop Beaujon, Intestinal Stroke Ctr, Dept Gastroenterol IBD & Intestinal Failure, AP HP, Clichy, France
[22] Lab Vasc & Translat Sci, INSERM UMR 1148, Paris, France
[23] Royal Free Hosp, Dept Hepatol & Liver Transplantat, London, England
[24] Hop Corentin Celton AP HP, Serv Geriatrie, Paris, France
[25] Kings Coll Hosp NHS Fdn Trust, Dept Haematol Med, London, England
[26] Northwestern Univ, Northwestern Mem Hosp, Chicago, IL USA
[27] Inst Liver & Biliary Sci, New Delhi, India
[28] Seth GS Med Coll & KEM Hosp, Dept Gastroenterol, Mumbai, India
[29] Hop Univ Geneve, Serv Chirurg Viscerale, Geneva, Switzerland
[30] Univ Hosp Birmingham, Queen Elizabeth Hosp, Dept Liver & Hepatopancreato Biliary Unit, Birmingham, England
[31] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, England
来源:
LANCET GASTROENTEROLOGY & HEPATOLOGY
|
2024年
/
9卷
/
09期
关键词:
INTRAHEPATIC PORTOSYSTEMIC SHUNT;
DIRECT ORAL ANTICOAGULANTS;
TRANSCATHETER THROMBOLYTIC THERAPY;
ACUTE MESENTERIC ISCHEMIA;
VENOUS SYSTEM THROMBOSIS;
MOLECULAR-WEIGHT HEPARIN;
LIVER-TRANSPLANTATION;
RISK-FACTORS;
CIRRHOTIC-PATIENTS;
POLYCYTHEMIA-VERA;
D O I:
10.1016/S2468-1253(24)00155-9
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
Portal vein thrombosis (PVT) refers to the development of a non-malignant obstruction of the portal vein, its branches, its radicles, or a combination. This Review first provides a comprehensive overview of all aspects of PVT, namely the specifics of the portal venous system, the risk factors for PVT, the pathophysiology of portal hypertension in PVT, the interest in non-invasive tests, as well as therapeutic approaches including the effect of treating risk factors for PVT or cause of cirrhosis, anticoagulation, portal vein recanalisation by interventional radiology, and prevention and management of variceal bleeding in patients with PVT. Specific issues are also addressed including portal cholangiopathy, mesenteric ischaemia and intestinal necrosis, quality of life, fertility, contraception and pregnancy, and PVT in children. This Review will then present endpoints for future clinical studies in PVT, both in patients with and without cirrhosis, agreed by a large panel of experts through a Delphi consensus process. These endpoints include classification of portal vein thrombus extension, classification of PVT evolution, timing of assessment of PVT, and global endpoints for studies on PVT including clinical outcomes. These endpoints will help homogenise studies on PVT and thus facilitate reporting, comparison between studies, and validation of future studies and trials on PVT.
引用
收藏
页码:859 / 883
页数:25
相关论文